<P>&nbsp;</P> <P align=justify><STRONG>Olympus Biotech, subsidiary of the Japanese group Olympus, is specialized in medical material and treatments</STRONG>. It has been located in Lyon since February 2011, where it develops and commercializes regenerative medicinal products. <STRONG><STRONG><A title="" href="https://www.aderly.com/compagnie-developpement-france/set-setting-up-company-development-europe-france,p,49,EN.jsp" target=_blank>The company was assisted by Aderly </A></STRONG>for its new set up in the center of Lyon.</STRONG> </P> <P align=justify>&nbsp;</P> <P align=justify>Olympus Biotech recently <STRONG>extended its offices to integrate a new R&amp;D center</STRONG>, which was originally based in the USA. <STRONG>Furthermore, this 760 sq.m. site is about to welcome staff from Paris as well as ten other employees</STRONG>, who will be hired within the upcoming months, according to Florian Kemmerich, President of Olympus Europe. </P> <P align=justify>&nbsp;</P> <P align=justify><STRONG>The biotech company chose to set up in Lyon because <A title="" href="https://www.aderly.com/biotechnologie-france-europe/life-science-biotechnology-cluster-france-europe,p,6,EN.jsp" target=_blank>the French city is well-known for its competences regarding biotechnologies</A></STRONG>, in particular thanks to its <STRONG>international cluster Lyonbiop&#244;le</STRONG>. Thus, the company intends to reach a 20% annual growth.<BR></P>